boston tides presentation, page-7

Hi Wayne,

Yes, we both highlighted that same quote from the article. :-)

What's worth re-highlighting is that Phylogica have only analysed a handful of the peptides with their second generation libraries and platform enhancements to identify endosomal escape.

Do you remember this presentation highlighting work with Roche?

http://www.phylogica.com/media/PhylogicaTechnologyCapabilities-web-Feb2012.pdf

They've come a long way since then.

Perhaps time in discussion is directly proportional to the size of the deal.

Could not agree more!

Regards,
Tony